• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可乐定和去甲替林:相互作用导致突破性阿片类药物戒断症状。

Lofexidine and desipramine: Interaction results in breakthrough opioid withdrawal symptoms.

出版信息

Int J Psychiatry Clin Pract. 2002;6(3):179-81. doi: 10.1080/136515002760276135.

DOI:10.1080/136515002760276135
PMID:24945207
Abstract

A patient was receiving treatment for concurrent opioid and stimulant dependency. When desipramine was added to his lofexidine regimen for treatment of stimulant withdrawal, there was an exacerbation of opioid withdrawal symptoms. With the increasing use of lofexidine for opioid withdrawal, clinicians need to be aware of the potential for interactions with tricyclic antidepressants in the treatment of concomitant stimulant users. (Int J Psych Clin Pract 2002; 6: 179-181 ).

摘要

一位患者同时患有阿片类药物和兴奋剂依赖,正在接受治疗。当用去甲替林来治疗兴奋剂戒断时,他的可乐定治疗方案加剧了阿片类药物戒断症状。随着可乐定在阿片类药物戒断中的应用越来越多,临床医生需要意识到在治疗同时使用兴奋剂的患者时,与三环类抗抑郁药相互作用的可能性。(Int J Psych Clin Pract 2002; 6: 179-181)。

相似文献

1
Lofexidine and desipramine: Interaction results in breakthrough opioid withdrawal symptoms.可乐定和去甲替林:相互作用导致突破性阿片类药物戒断症状。
Int J Psychiatry Clin Pract. 2002;6(3):179-81. doi: 10.1080/136515002760276135.
2
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.可乐定,一种用于阿片类药物戒毒的 α2-受体激动剂。
Ann Pharmacother. 2010 Feb;44(2):343-51. doi: 10.1345/aph.1M347. Epub 2009 Dec 29.
3
Lofexidine for acute opioid withdrawal: A clinical case series.用于急性阿片类药物戒断的洛非西定:临床病例系列
Ment Health Clin. 2020 Sep 30;10(5):259-263. doi: 10.9740/mhc.2020.09.259. eCollection 2020 Sep.
4
The Role of Lofexidine in Management of Opioid Withdrawal.洛非西定在阿片类药物戒断管理中的作用。
Pain Ther. 2019 Jun;8(1):67-78. doi: 10.1007/s40122-018-0108-7. Epub 2018 Dec 18.
5
Clinical Efficacy and Safety Profile of Lofexidine Hydrochloride in Treating Opioid Withdrawal Symptoms: A Review of Literature.盐酸洛非西定治疗阿片类药物戒断症状的临床疗效与安全性概况:文献综述
Cureus. 2019 Jun 4;11(6):e4827. doi: 10.7759/cureus.4827.
6
Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials.洛非西定减轻阿片类药物戒断症状的疗效:两项随机、安慰剂对照试验的结果。
J Drug Assess. 2020 Jan 8;9(1):13-19. doi: 10.1080/21556660.2019.1704416. eCollection 2020.
7
In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.住院戒毒程序、治疗留存率及治疗后阿片类药物使用情况:洛非西定+纳洛酮、洛非西定+安慰剂与美沙酮的比较
Drug Alcohol Depend. 2007 Apr 17;88(1):91-5. doi: 10.1016/j.drugalcdep.2006.09.020. Epub 2006 Oct 24.
8
Low efficacy of non-opioid drugs in opioid withdrawal symptoms.非阿片类药物在阿片类药物戒断症状方面疗效不佳。
Addict Biol. 2005 Jun;10(2):165-9. doi: 10.1080/13556210500123514.
9
The impact of naloxone/lofexidine combination treatment on the opiate withdrawal syndrome.纳洛酮/洛非西定联合治疗对阿片类戒断综合征的影响。
Addict Biol. 2001 Apr;6(2):147-156. doi: 10.1080/13556210020040226.
10
Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.使用洛非西定(可乐定类似物,副作用较少)进行阿片类药物戒断。
J Clin Psychiatry. 1983 Sep;44(9):335-7.